-
My Account
My Account
BSE Live
Jan 15, 16:00Prev. Close
3725.15
Open Price
3750.00
Bid Price (Qty.)
3645.00 (23)
Offer Price (Qty.)
3652.00 (5)
NSE Live
Jan 15, 16:01Prev. Close
3724.70
Open Price
3760.00
Bid Price (Qty.)
3644.80 (28)
Offer Price (Qty.)
0.00 (0)
| Yearly Results of Divis Laboratories (in Rs. Cr.) | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | |
| Net Sales/Income from operations | 5,310.57 | 4,879.66 | 3,837.23 | 4,054.73 | 3,742.48 | |
| Other Operating Income | -- | -- | -- | 11.04 | 7.37 | |
| Total Income From Operations | 5,310.57 | 4,879.66 | 3,837.23 | 4,065.77 | 3,749.85 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 2,182.66 | 2,082.05 | 1,524.28 | 1,563.19 | 1,472.43 | |
| Purchase of Traded Goods | -- | -- | -- | -- | -- | |
| Increase/Decrease in Stocks | -94.10 | -244.22 | -19.38 | -21.61 | 22.03 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 608.36 | 530.72 | 446.27 | 459.15 | 352.95 | |
| Depreciation | 185.95 | 168.81 | 142.42 | 123.26 | 118.10 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 798.21 | 662.15 | 635.43 | 627.28 | 501.95 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1,629.49 | 1,680.15 | 1,108.21 | 1,314.50 | 1,282.39 | |
| Other Income | 189.86 | 156.58 | 112.48 | 75.98 | 95.91 | |
| P/L Before Int., Excpt. Items & Tax | 1,819.35 | 1,836.73 | 1,220.69 | 1,390.48 | 1,378.30 | |
| Interest | 6.06 | 3.50 | 1.33 | 2.25 | 3.01 | |
| P/L Before Exceptional Items & Tax | 1,813.29 | 1,833.23 | 1,219.36 | 1,388.23 | 1,375.29 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 1,813.29 | 1,833.23 | 1,219.36 | 1,388.23 | 1,375.29 | |
| Tax | 440.58 | 500.58 | 349.78 | 334.96 | 264.45 | |
| P/L After Tax from Ordinary Activities | 1,372.71 | 1,332.65 | 869.58 | 1,053.27 | 1,110.84 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 1,372.71 | 1,332.65 | 869.58 | 1,053.27 | 1,110.84 | |
| Equity Share Capital | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | |
| Reserves Excluding Revaluation Reserves | 7,263.60 | 6,920.22 | 5,906.56 | 5,355.82 | 4,297.05 | |
| Equity Dividend Rate (%) | 800.00 | 800.00 | 500.00 | 500.00 | 500.00 | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 51.71 | 50.20 | 32.76 | 39.68 | 41.84 | |
| Diluted EPS | 51.71 | 50.20 | 32.76 | 39.68 | 41.84 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 51.71 | 50.20 | 32.76 | 39.68 | 41.84 | |
| Diluted EPS. | 51.71 | 50.20 | 32.76 | 39.68 | 41.84 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
07.11.2020
10.08.2020
Divis Labs Consolidated June 2020 Net Sales at Rs 1,730.47 crore, up 48.81% Y-o-Y
10.08.2020
Divis Labs Standalone June 2020 Net Sales at Rs 1,709.96 crore, up 50.01% Y-o-Y
08.08.2020
